200 related articles for article (PubMed ID: 32394465)
1. A 5-HT
Hatini PG; Commons KG
Eur J Neurosci; 2020 Nov; 52(10):4370-4374. PubMed ID: 32394465
[TBL] [Abstract][Full Text] [Related]
2. Serotonin abnormalities in Dravet syndrome mice before and after the age of seizure onset.
Hatini PG; Commons KG
Brain Res; 2019 Dec; 1724():146399. PubMed ID: 31445030
[TBL] [Abstract][Full Text] [Related]
3. A novel rat model of Dravet syndrome recapitulates clinical hallmarks.
Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H
Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561
[TBL] [Abstract][Full Text] [Related]
4. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
5. Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.
Pernici CD; Mensah JA; Dahle EJ; Johnson KJ; Handy L; Buxton L; Smith MD; West PJ; Metcalf CS; Wilcox KS
Epilepsia; 2021 Jul; 62(7):1665-1676. PubMed ID: 34002394
[TBL] [Abstract][Full Text] [Related]
6. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
[TBL] [Abstract][Full Text] [Related]
7. A selective Na
Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.
Zhang Y; Kecskés A; Copmans D; Langlois M; Crawford AD; Ceulemans B; Lagae L; de Witte PA; Esguerra CV
PLoS One; 2015; 10(5):e0125898. PubMed ID: 25965391
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
Anderson LL; Bahceci DA; Hawkins NA; Everett-Morgan D; Banister SD; Kearney JA; Arnold JC
PLoS One; 2023; 18(1):e0280842. PubMed ID: 36701411
[TBL] [Abstract][Full Text] [Related]
10. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
[TBL] [Abstract][Full Text] [Related]
11. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a
Bahceci D; Anderson LL; Kevin RC; Doohan PT; Arnold JC
Cannabis Cannabinoid Res; 2023 Jun; 8(3):495-504. PubMed ID: 36269656
[No Abstract] [Full Text] [Related]
13. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome.
Gu F; Parada I; Yang T; Longo FM; Prince DA
Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35165147
[TBL] [Abstract][Full Text] [Related]
14. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
Niibori Y; Lee SJ; Minassian BA; Hampson DR
Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the action of serotonin by three different mechanisms prevents spontaneous seizure-induced mortality in Dravet mice.
Guo J; Min D; Farrell EK; Zhou Y; Faingold CL; Cotten JF; Feng HJ
Epilepsia; 2024 Jun; 65(6):1791-1800. PubMed ID: 38593237
[TBL] [Abstract][Full Text] [Related]
16. Switching from zonisamide to perampanel improved the frequency of seizures caused by hyperthermia in Dravet syndrome: a case report.
Horiuchi K; Kudo A; Nakamura S; Yamada K; Inoue T; Fujii S; Oshima Y
J Med Case Rep; 2024 Jan; 18(1):3. PubMed ID: 38167335
[TBL] [Abstract][Full Text] [Related]
17. Early clinical features and diagnosis of Dravet syndrome in 138 Chinese patients with SCN1A mutations.
Xu X; Zhang Y; Sun H; Liu X; Yang X; Xiong H; Jiang Y; Bao X; Wang S; Yang Z; Wu Y; Qin J; Lin Q; Wu X
Brain Dev; 2014 Sep; 36(8):676-81. PubMed ID: 24168886
[TBL] [Abstract][Full Text] [Related]
18. Investigation of MicroRNA-134 as a Target against Seizures and SUDEP in a Mouse Model of Dravet Syndrome.
Gerbatin RR; Augusto J; Morris G; Campbell A; Worm J; Langa E; Reschke CR; Henshall DC
eNeuro; 2022; 9(5):. PubMed ID: 36240080
[TBL] [Abstract][Full Text] [Related]
19. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
20. Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?
Verbeek NE; Wassenaar M; van Campen JS; Sonsma A; Gunning B; Knoers N; Lindhout D; Jansen FE; Leijten F; Brilstra EH; Kasteleijn-Nolst Trenité D
Epilepsy Behav; 2015 Jun; 47():39-44. PubMed ID: 26021464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
